September 14, 2020

Studying the human genome to understand the risk of autism

A team of researchers at CHU Sainte-Justine and Université de Montréal has succeeded in using bioinformatics to develop a statistical model to assess how the gain or loss of genetic material impacts the risk of autism. The results of this work are presented in the American Journal of Psychiatry. This […]
September 14, 2020

Why is COVID-19 more severe in men and elders?

The immune system usually mounts a strong immune response to infection by SARS-CoV-2, the virus that causes COVID-19. That defensive response, however, appears to be weaker in men and people over the age of 60, a study led by researchers at the University of Washington School of Medicine in Seattle has […]
September 13, 2020

Preserving Brain Tissue with Stem Cells

UT Health physicians use supercomputers to interpret results of traumatic brain injury clinical trial. Individuals with traumatic brain injuries, or TBIs, frequently experience the shrinking or atrophying of brain tissue near where the injury occurred, causing additional damage beyond the original harm. If this can be prevented, many could function […]
September 11, 2020

Seeing the eye like never before

Researchers are able to visualize the retina's function at the cellular level, which will help accelerate cures for blinding diseases. While there is no cure for blindness and macular degeneration, scientists have accelerated the process to find a cure by visualizing the inner workings of the eye and its diseases at […]
September 11, 2020

Mutation leading to biological changes may play role in cancer

A new study from McGill University’s Goodman Cancer Research Centre (GCRC) has revealed significant biological changes in mice expressing an activated, mutant form of the Estrogen Receptor alpha (ER alpha), shedding new light on the role of this important gene in development and cancer. Over-expressed in approximately 70 % of breast cancer cases, the Estrogen Receptor is often associated […]
September 11, 2020

Powerful push to use AI for cancer immunotherapy

For artificial intelligence (AI) tools being developed at Case Western Reserve University to have impact in the fight against cancer, they’re going to have to be validated in rigorous human clinical trials. That validation may be a step closer following two recent agreements among bioengineering pioneer Anant Madabhushi, a longtime […]
September 11, 2020

Imagery reveals autism-related brain differences

People with autism spectrum disorder have lower levels of a protein that regulates the amount of serotonin in the brain, a paper from Karolinska Institutet in Sweden published in the journal Molecular Psychiatry reports. For their study, the researchers used a molecular brain imaging technique to compare people with and […]
September 10, 2020

Probiotic skin therapy improves eczema in children, NIH study suggests

An experimental treatment for eczema that aims to modify the skin microbiome safely reduced disease severity and increased quality of life for children as young as 3 years of age, a National Institutes of Health study has found. These improvements persisted for up to eight months after treatment stopped, researchers report […]
September 10, 2020

New Nanosystem from TAU Enhances Treatment for Melanoma in Animal Models

Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma. The nanocarrier is a biocompatible and biodegradable polymer, which comprises repeating units […]
September 10, 2020

As It Unfolds

New research from Harvard Medical School and Boston Children’s Hospital, in collaboration with Boston University and the University of California, Los Angeles, provides an accelerated platform for studying early-stage lung cancer and identifying and testing potential treatments: “organoids” created from lung cells. The researchers reported in Cell Stem Cell that […]
September 10, 2020

The genetics of blood: a global perspective

What’s the risk of different human populations to develop a disease? To find out, a team led by Université de Montréal professor Guillaume Lettre created an international consortium to study the blood of hundreds of thousands of people worldwide. In one of the largest studies of its kind, published in […]
September 9, 2020

New gene regulation model provides insight into brain development

A well-known protein family binds to many more RNA sequences than previously thought in order to help neurons grow. In every cell, RNA-binding proteins (RBPs) help tune gene expression and control biological processes by binding to RNA sequences. Researchers often assume that individual RBPs latch tightly to just one RNA […]
September 9, 2020

Research unravels what makes memories so detailed and enduring

In years to come, personal memories of the COVID-19 pandemic are likely to be etched in our minds with precision and clarity, distinct from other memories of 2020. The process which makes this possible has eluded scientists for many decades, but research led by the University of Bristol has made […]
September 8, 2020

How we sleep today may forecast when Alzheimer’s disease begins

What would you do if you knew how long you had until Alzheimer’s disease set in? Don’t despair. New UC Berkeley research suggests one defense against this virulent form of dementia — for which no treatment currently exists — is deep, restorative sleep, and plenty of it. Neuroscientists Matthew Walker […]
September 8, 2020

The brain can induce diabetes remission in rodents, but how?

In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood. Clarifying how this […]
September 8, 2020

Seeing Progress

As we get older, many of our body’s processes start slowing down. For instance, a cut on the hand will take longer to heal after middle age than in youth. That said, it still heals. Unfortunately, this isn’t the case for the cells at the back of the eye, which […]
September 7, 2020

Dues forgetting a name or word mean that I have dementia?

The number of cases of dementia in the U.S. is rising as baby boomers age, raising questions for boomers themselves and also for their families, caregivers and society. Dementia, which is not technically a disease, but a term for impaired ability to think, remember or make decisions, is one of […]
September 7, 2020

Researchers offer insights into aging

What determines the life span of a mouse, alligator, dog or human? A team of scientists at the University of Georgia believes they have new insight into this age-old question. Emily Bertucci and Benjamin B. Parrott, a research team at the Odum School of Ecology and the Savannah River Ecology Laboratory, […]
September 7, 2020

Researchers find a cause and possible treatment for Fragile X

Yale scientists have discovered an underlying mechanism for Fragile X syndrome — a leading cause of autism and the primary genetic driver of intellectual disability — as well as a drug that reversed the underlying abnormality and autism-like behaviours in mice. Their research appears in the edition of the journal […]
September 7, 2020

Hearing loss may be a contributing factor to Alzheimer's disease

Aging is something we all have to deal with. And it’s no fun – your body gradually loses some of its capacities and you’re left wondering what you will be able to do tomorrow. One of the parts of aging is losing senses – older people tend to have impaired […]
September 6, 2020

You may be genetically predisposed to use illicit drugs

Some people are into the sort of behaviour that we know is harmful. For example, millions and millions of people drink, use illicit drugs, smoke, gamble and so on. You may be one of those people. But why? This new study, led by scientists from UCL, found that these harmful […]
September 4, 2020

Agreement tackles Alzheimer’s disease

Cardiff University has signed an agreement with Cytox to help the company develop a genetic risk assessment tool for Alzheimer’s disease. Under the licence, Oxford- and Manchester-based Cytox will access the University’s intellectual property (IP) regarding polygenic risk scoring algorithms for predicting the future onset of Alzheimer’s disease. Cytox will […]
September 3, 2020

Engineers reprogram yeast cells to become microscopic drug factories

By genetically reprogramming the cellular machinery of yeast they created microscopic factories that convert sugars and amino acids into plant-based drugs. Since antiquity, cultures on nearly every continent have discovered that certain plant leaves, when chewed or brewed or rubbed on the body, could relieve diverse ailments, inspire hallucinations or, […]
September 3, 2020

New Connections Reveal How Cancer Evades the Immune System

If cancer is a series of puzzles, new study pieces together how several of those puzzles connect to form a bigger picture. One major piece is the immune system and the question of why certain immune cells stop doing their job. Another piece involves how histones are altered within immune […]
September 3, 2020

How mechanical forces nudge tumors toward malignancy

All cancers are the result of cells that have gone haywire, multiplying out of control and expanding beyond their normal constraints. But not all tumors are the same: for reasons that remain poorly understood, some are more likely to become aggressive and metastasize to other parts of the body. New […]
September 2, 2020

Scientists Develop First Drug-Like Compounds to Inhibit Elusive Cancer-Linked Enzymes

A team of scientists from the University of Michigan Rogel Cancer Center has developed the first drug-like compounds to inhibit a key family of enzymes whose malfunction is associated with several types of cancer, including an aggressive form of childhood leukaemia. The enzymes — known as the nuclear receptor-binding SET domain […]